Usana Health SciencesUSNA
USNA
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
4% more funds holding
Funds holding: 146 [Q3] → 152 (+6) [Q4]
2% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 47
0.8% more ownership
Funds ownership: 55.77% [Q3] → 56.57% (+0.8%) [Q4]
4% less capital invested
Capital invested by funds: $403M [Q3] → $387M (-$15.9M) [Q4]
39% less call options, than puts
Call options by funds: $50K | Put options by funds: $82K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$36
32%
upside
Avg. target
$36
32%
upside
High target
$36
32%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
DA Davidson Linda Bolton Weiser 23% 1-year accuracy 24 / 105 met price target | 32%upside $36 | Neutral Maintained | 27 Feb 2025 |
Financial journalist opinion
Neutral
PRNewsWire
8 hours ago
USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony
SALT LAKE CITY , April 1, 2025 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest marks April's convergence of International Guitar Month and Stress Awareness Month, as a perfect pairing that celebrates the healing power of music for mental well-being. While music has long been heralded as a universal remedy, the guitar offers far more than just melodies.
Neutral
PRNewsWire
4 weeks ago
USANA Exec. Chairman Kevin Guest Invites All to Celebrate March's Listening Awareness Month
SALT LAKE CITY , March 3, 2025 /PRNewswire/ -- USANA Executive Chairman Kevin Guest announces the company's enthusiastic support for March's Listening Awareness Month, encouraging individuals everywhere to explore and celebrate the transformational power of listening. Through heartfelt personal stories and actionable insights, Guest emphasizes how active listening can strengthen personal and professional relationships and foster deeper understanding.
Neutral
Seeking Alpha
1 month ago
USANA Health Sciences, Inc. (USNA) Q4 2024 Earnings Conference Call Transcript
USANA Health Sciences, Inc. (NYSE:USNA ) Q4 2024 Earnings Conference Call February 26, 2025 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Brent Neidig - Chief Commercial Officer Doug Hekking - CFO Walter Noot - COO Conference Call Participants Anthony Lebiedzinski - Sidoti Christina Xue - D.A. Davidson Ivan Feinseth - Tigress Financial Partners Doug Lane - Water Tower Research Operator Greetings, and welcome to the USANA Health Sciences' Fourth Quarter Conference Call.
Positive
Zacks Investment Research
1 month ago
USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.87 per share a year ago.
Neutral
Business Wire
1 month ago
USANA Health Sciences Reports Fourth Quarter and Full Year 2024 Results and Provides Fiscal Year 2025 Outlook
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) (the “Company”) today announced financial results for its fiscal fourth quarter and fiscal year ended December 28, 2024. The Company completed the acquisition of a 78.8% controlling ownership stake of Hiya Health Products, LLC (“Hiya”) on December 23, 2024. Consequently, the Company's fourth quarter and fiscal year 2024 include the effect of less than a week of Hiya's operating results, which were not significant to the C.
Positive
Zacks Investment Research
1 month ago
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Positive
Zacks Investment Research
1 month ago
5 Low Price-to-Book Stocks Worthy of Value Investors' Attention
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, KT, GBX, USNA and ENS are some such stocks.
Positive
Zacks Investment Research
1 month ago
USNA or STVN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
1 month ago
5 Promising Price-to-Book Value Stocks to Buy in February
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, GBX, KT and ENS are some such stocks.
Neutral
PRNewsWire
1 month ago
Kevin Guest Encourages Confidence, Personal Growth for International Boost Self-Esteem Month
SALT LAKE CITY , Feb. 3, 2025 /PRNewswire/ -- Throughout February, Kevin Guest invites individuals everywhere to celebrate International Boost Self-Esteem Month—a time dedicated to building confidence, fostering self-worth and inspiring personal empowerment. Because self-esteem is the cornerstone of a healthy, fulfilling life—shaping relationships, fueling careers and influencing overall well-being—now is the ideal time for individuals to prioritize themselves and take meaningful steps toward becoming more confident and empowered.
Charts implemented using Lightweight Charts™